Role of the acetylcholine in the virus-induced bronchoconstriction

Marco Contoli (Ferrara, Italy), Marco Contoli, Andrea Marcellini, Paolo Casolari, Gaetano Caramori, Alberto Papi

Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Session: Preclinical pharmacology: drug targets and mechanisms of action
Session type: Thematic Poster
Number: 4103
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marco Contoli (Ferrara, Italy), Marco Contoli, Andrea Marcellini, Paolo Casolari, Gaetano Caramori, Alberto Papi. Role of the acetylcholine in the virus-induced bronchoconstriction. Eur Respir J 2016; 48: Suppl. 60, 4103

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Cytokine patterns and latent viruses in patients with severe asthma and COPD
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma.
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

Investigating the interaction between bronchoconstriction and cough in asthma
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016

Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014

Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013

Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015


Assessment of sputum prostaglandins and leukotrienes in COPD exacerbations
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Effects of PKR inhibitor on poly (I:C)-induced exacerbation of severe asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


Airway glucose in COPD exacerbations
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016



Spectrum of viral pathogens in adults patients with infectious exacerbations of bronchial asthma
Source: Annual Congress 2013 –Viral infections
Year: 2013


Pulmonary response to salbutamol inhalation using dynamic OE-MRI in patients with asthma
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013


Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016

Characterisation of asthma patients with persistent airflow obstruction
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016


Species comparison of interleukin-13 induced airway hyperreactivity as model for allergic asthma
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

Airway hyperresponsiveness (AHR) of small airways assessed by impulse oscillation (IOS) in adult asthma
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015

Bronchodilator effect of a novel inhaled dual PDE3/4 inhibitor, RPL554, in mild allergic asthma & rhinitis
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013